Form 4 Filing: NEWHALL CHARLES W III Acquires shares of SUPERNUS PHARMACEUTICALS, INC.

INSIDER TRANSACTION

⚡ MATERIALITY: 1/10

corporate issuer

SUPERNUS PHARMACEUTICALS, INC.

Ticker: not matched

Transaction Value

N/A (Non-Open-Market)

Price/Share: $0.00 (Non-Open-Market)

transaction date

2026-11-02

Shares: 124,119

HillSignal AI Analytical Report

SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, NEWHALL CHARLES W III, holds the title of Director at SUPERNUS PHARMACEUTICALS, INC..

On 2026-11-02, the insider transacted 124,119 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.

Executive Summary Summary

NEWHALL CHARLES W III (Director) transacted $0 of $SUPN

Post-Transaction Position: 0 shares

SEC Accession No: 0001005544-26-000006 (CIK: 1005544)

Verified Multi-Source Index

Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.

SEC EDGAR FilingView Source Form 4

OpenCorporates RegistryVerify Corporate Identity

Google NewsSUPERNUS PHARMACEUTICALS, INC. News Coverage